Cargando…
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
Background: The potential value of patient preference studies has been recognized in clinical individual treatment decision-making between clinicians and patients, as well as in upstream drug decision-making. Drug developers, regulators, reimbursement and Health Technology Assessment (HTA) bodies ar...
Autores principales: | Petrocchi, Serena, Janssens, Rosanne, Oliveri, Serena, Arnou, Reinhard, Durosini, Ilaria, Guiddi, Paolo, Louis, Evelyne, Vandevelde, Marie, Nackaerts, Kristiaan, Smith, Meredith Y., Galli, Giulia, de Marinis, Filippo, Gianoncelli, Letizia, Pravettoni, Gabriella, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970036/ https://www.ncbi.nlm.nih.gov/pubmed/33746750 http://dx.doi.org/10.3389/fphar.2021.602112 |
Ejemplares similares
-
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy
por: Janssens, Rosanne, et al.
Publicado: (2021) -
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
por: Durosini, Ilaria, et al.
Publicado: (2021) -
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting
por: Monzani, Dario, et al.
Publicado: (2021) -
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
por: Oliveri, Serena, et al.
Publicado: (2023) -
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population
por: Oliveri, Serena, et al.
Publicado: (2021)